Clinical and Electrophysiological Characteristics of Very Early Guillain-Barré Syndrome.

PURPOSE This study compared the clinical and electrodiagnostic (EDX) features and long-term outcomes of patients with very early Guillain-Barré syndrome (VEGBS, duration of illness ≤4 days) and those with early/late (>4 days)-presenting GBS. METHODS One hundred patients with GBS were clinically evaluated and categorized into VEGBS and early/late GBS groups. Electrodiagnostic studies were performed on the bilateral median, ulnar, and fibular motor nerves and the bilateral median, ulnar, and sural sensory nerves. Admission and peak disability were assessed using the 0 to 6 Guillain-Barré Syndrome Disability Scale (GBSDS). The primary outcome was disability at 6 months, which was categorized as complete (GBSDS ≤1) or poor (GBSDS ≥2). The secondary outcomes were frequencies of abnormal electrodiagnostic findings, in-hospital progression, and mechanical ventilation (MV). RESULTS Patients with VEGBS had higher peak disability (median 5 vs. 4; P = 0.02), frequent in-hospital disease progression (42.9% vs. 19.0%, P < 0.01), needed MV (50% vs. 22.4%; P < 0.01), and less frequent albuminocytologic dissociation (52.4% vs. 74.1%; P = 0.02) than those with early/late GBS. Thirteen patients were lost to follow-up at 6 months (nine patients with VEGBS and four patients with early/late GBS). The proportion of patients with complete recovery at 6 months was comparable (60.6% vs. 77.8%; P = ns). Reduced d-CMAP was the most common abnormality, noted in 64.7% and 71.6% of patients with VEGBS and early/late GBS, respectively (P = ns). Prolonged distal motor latency (≥130%) was more common in early/late GBS than in VEGBS (36.2% vs. 25.4%; P = 0.02), whereas absent F-waves were more frequent in VEGBS (37.7% vs. 28.7%; P = 0.03). CONCLUSIONS Patients with VEGBS were more disabled at admission than those with early/late GBS. However, 6 month's outcomes were similar between the groups. F-wave abnormalities were frequent in VEGBS, and distal motor latency prolongation was common in early/late GBS.

[1]  J. Kalita,et al.  Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barré Syndrome , 2020, Journal of Clinical Neuroscience.

[2]  E. Gallardo,et al.  Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study , 2019, Clinical neurophysiology practice.

[3]  Yonghui Dang,et al.  Very Early Neurophysiological Study in Guillain-Barre Syndrome , 2018, European Neurology.

[4]  Luigi Ippoliti,et al.  Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis , 2017, Clinical Neurophysiology.

[5]  N. Yuki,et al.  Sural-sparing is seen in axonal as well as demyelinating forms of Guillain–Barré syndrome , 2015, Clinical Neurophysiology.

[6]  A. Echaniz-Laguna,et al.  Early electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy: A retrospective study of 58 patients , 2014, Clinical Neurophysiology.

[7]  A. Uncini,et al.  Outcome and its predictors in Guillain–Barré syndrome , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  A. Alentorn,et al.  Very early electrodiagnostic findings in Guillain‐Barré syndrome , 2011, Journal of the peripheral nervous system : JPNS.

[9]  N. Yuki,et al.  Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome , 2005, Neurology.

[10]  S. Vucic,et al.  Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy , 2004, Clinical Neurophysiology.

[11]  P. Gordon,et al.  Early electrodiagnostic findings in Guillain-Barré syndrome. , 2001, Archives of neurology.

[12]  N. Yuki,et al.  Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies , 2000, Journal of neurology, neurosurgery, and psychiatry.

[13]  R. Hughes,et al.  Guillain-Barré syndrome , 1994, The Lancet.

[14]  L. Kiers,et al.  Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy. , 1994, Electroencephalography and clinical neurophysiology.

[15]  P. Schmitz,et al.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.

[16]  J. Albers,et al.  Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy , 1985, Muscle & nerve.

[17]  W. Brown,et al.  Conduction block and denervation in Guillain-Barré polyneuropathy. , 1984, Brain : a journal of neurology.

[18]  R. Hughes,et al.  CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY , 1978, The Lancet.

[19]  Judith Drenthen,et al.  Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. , 2014, Brain : a journal of neurology.

[20]  R. Olney.  Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. , 1999, Muscle & nerve. Supplement.